GlassScriptPhysician profile
Michael J Pattillo
NPI 1992798805
$5,196.57
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $448 · 2021: $1,004 · 2022: $1,116 · 2023: $1,347 · 2024: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,935 · Education: $46.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,934.70 |
| Education | $46.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,157.08 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $817.87 | 2019-2024 | Farxiga, Breztri |
| Amgen INC. | $356.58 | 2019-2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $338.08 | 2019-2024 | Shingrix, Bexsero, Arexvy |
| Pfizer INC. | $304.07 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $181.39 | 2019-2023 | Vaxneuvance, Gardasil 9, Rotateq |
| Sanofi Pasteur INC. | $172.46 | 2021-2024 | |
| Novo Nordisk INC | $157.21 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.23 | 2019-2024 | Jardiance |
| Exact Sciences Corporation | $149.66 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $128.71 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $121.60 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $121.21 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.09 | 2022-2023 | Trintellix, Gattex |
| Supernus Pharmaceuticals, INC. | $98.63 | 2022-2023 | Qelbree |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pattillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.